Detection of residual disease after neoadjuvant therapy in breast cancer using personalized circulating tumor DNA analysis
Bradon R. McDonald, Tania Contente‐Cuomo, Stephen‐John Sammut, Ahuva Odenheimer-Bergman, Brenda J. Ernst, Nieves Perdigones, Suet‐Feung Chin, Maria Farooq, Rosa Mejia, Patricia A. Cronin, Karen S. Anderson, Heidi Kosiorek, DW Northfelt, Ann E. McCullough, Bhavika Patel, , Muhammed Murtaza
A personalized ctDNA test achieves high accuracy for residual disease detection after neoadjuvant therapy in breast cancer.
Science Translational Medicine · Aug 7, 2019Peer-reviewedGenomics